Amikacin SDRIFE on the basis of neomycin cross-reactivity managed with desensitization and treating through. Vincent MN, Jaggers J, Fiske C, Phillips EJ, et al. Ann Allergy Asthma Immunol 2024 Apr 20:S1081-1206(24)00239.

Read + Share

Amedeo Smart

Independent Medical Education

Vincent MN, Jaggers J, Fiske C, Phillips EJ, et al. Amikacin SDRIFE on the basis of neomycin cross-reactivity managed with desensitization and treating through. Ann Allergy Asthma Immunol 2024 Apr 20:S1081-1206(24)00239.
PMID: 38648976